
Marquette will offer a new, non-thesis master’s degree in biomedical engineering beginning in fall 2008. The proposed program, approved by the Marquette Board of Trustees this month, is specifically designed for engineers working full time for medical device companies. The 30-credit curriculum will include five possible areas of study: biocomputing, bioimaging, bioinstrumentation, biomechanics and biorehabilitation. Three core courses will provide a common foundation in physiology, healthcare technology management and the integration of life sciences and engineering.
“This degree specifically addresses the needs of the medical device industry,” said Dr. Kristina Ropella, chair of the Department of Biomedical Engineering. “As the technical and management requirements for engineers increase, institutions of higher education need to address the demands for continuing education.”
The aim of the new program is to advance technical knowledge and skill with significant exposure to the challenges in medicine. Many medical device companies are within driving distance of Marquette, including GE Healthcare, Emageon, BCI, Kimberly-Clark, Abbott Laboratories, Baxter and Tomotherapy.
Students will be able to complete the master’s work in two years, taking nine credits during the academic year and six credits for two summers. To enroll, students will have to have a bachelor’s degree in engineering and at least one year of post-baccalaureate industry experience.
For more information about this new program, contact Ropella at (414) 288-3375.
Marquette experts can offer expertise and insights on hundreds of topics by helping you over the phone, sitting down for an interview or providing background to give a story more context.